Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Myasthenia Gravis, a Rare Autoimmune Disorder [Yahoo! Finance]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
the enrollment of the first patient in the new PPD™ CorEvitas™ Myasthenia Gravis (MG) Registry. This nationwide registry will collect data from MG patients across the United States to study and evaluate existing and emerging MG therapies, tracking health conditions, safety issues, medication usage and overall treatment effectiveness. By leveraging real-world data, the registry will enhance our understanding of MG and improve patient care. MG is a rare autoimmune disorder of the neuromuscular junction causing muscle weakness and fatigue that worsens with activity and may fluctuate daily. While more common in adults, MG can affect people of all ages, and the exact cause is unknown. It is estimated that over 70,000 people in the U.S. have been diagnosed with MG. Patients can experience a wide range of symptoms that can vary from mild to severe and may include periods of remission with no symptoms, severe episodes that worsen with daily activities, or myasthenic crisis, which involves s
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Thermo Fisher's New Asia Bioprocessing Network Might Change The Case For Investing In Thermo Fisher Scientific (TMO) [Yahoo! Finance]Yahoo! Finance
- What Made Thermo Fisher Scientific (TMO) a Solid Performer in Q3? [Yahoo! Finance]Yahoo! Finance
- GetSpares Expands Rapid-Response Thermo Fisher Chiller Repair Services to Support Semiconductor Manufacturing IndustryPR Web
- Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design CentersBusiness Wire
- Thermo Fisher Scientific (NYSE:TMO) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $670.00 price target on the stock.MarketBeat
TMO
Earnings
- 10/22/25 - Beat
TMO
Sec Filings
- 12/5/25 - Form 4
- 12/4/25 - Form 4
- 12/4/25 - Form 144
- TMO's page on the SEC website